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Abstract: 
A simple protocol for the synthesis of 2-amino-1, 3, 4-oxadiazole derivatives using iodoaceticacid as a 
cyclodesulfurization agent. This method is also applicable to the synthesis of various substituted 2-amino-1, 3, 
4-oxadiazole derivatives such as 5-(2-bromophenyl)-N-phenyl-1, 3, 4-oxadiazol-2-amine. The synthesized 
methodology was simple and hazardless, it’s giving good yield.  
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1. Introduction:  
 1, 3, 4-Oxodiazoles have found extensive use as pharmacopores due to their metabolic property. 2-
amino-1, 3, 4-oxodiazoles have wide range of biological activities such as antimicrobial agents, anti-
inflammatory, anti-cancer, muscle relaxants and mitotic [1]. Some 2,5-diaryl substituted 1,3,4-oxodiazoles act 
as a platlet aggregators [2], antibacterial [3], insecticidal [4], herbicidal/fungicidal [5] and hypotension [6]. 
Synthesis of 1, 3, 4-oxodiazoles involvescyclodesulfurization of thiosemicarbazide [7], isoselenocyanates via 
cyclodeselenization [8], using polymer-supported reagents [9], phosphonium mediated reagents [10], 
hypervalent Iodine mediatedmethod [11]. The reported method was frequently requires heating and long 
reaction time, furthermore formation of urea side product can pose significant challenges during purification. 
We recognized that this process could be considerably simplified by using iodoacetic acid as a 
cyclodesulfurization agent and using ethanol solvent to provide desired product at 65°C, 3 hours without 
formation of side product with high yields. 
2. Experimental Section: 
A. Methods and Materials: The chemicals of substituted aryl esters, thiophosgene, substituted anilines, ethanol 
and dichloromethane were obtained from Avraand Sigma Aldrich. Silica gel (TLC and Column grade) were 
purchased from Merck. The NMR spectra of the compounds have been recorded on Bruker AV400 spectrometer 
operating at 400 MHz for recording 
1
HNMR spectra in DMSOas solvent using TMS as internal standard. Mass 
spectra have been recorded on SHIMADZU spectrometer using chemical ionization technique. 
B. Synthesis: 
1. General Preparation of Substituted Benzohydrazide Compounds (2a-b) 
General Procedure:  
To a solution of substituted aryl ester (1a-b) (5g, 0.0239mmol, 1eq), and hydrazine hydrate (5.81g, 
0.116mmol, 5eq) in 50 ml of anhydrous ethanol was added at room temperature. The reaction mixture was 
heated at 80°C and stirred for   5hrs. TLC was indicated absence of starting materials. The residue was diluted 
with water and then extracted with dichloro methane (300mlX3). The combined organic layer washed with brine 
solution and dried with sodium sulphate and filtered, concentrated to afford compound (2a-b) as a white colour 
powder. The crude product was taken next step without further purification. 
2. General Preparation of Substituted Phenylthiosemicarbazide Compounds (3a-b) 
General Procedure:  
To a solution of compounds (2a-b) (2g, 0.0092mmol, 1eq) and phenyl isothiocyanate (1.25g, 
0.0092mmol, 1eq) in 20 ml of dichloromethane was added at 0°C. The reaction mixture was stirred for 2hrs at 
room temperature. TLC was indicated absence of starting materials. The residue was diluted with water and then 
extracted with dichloro methane (30ml*3times). The combined organic layer washed with brine solution and 
dried with sodium sulphate and filtered, concentrated to affordcompound (3a-b) as a light brown colour powder. 
The crude product was taken next step without further purification. 
3. General Preparation of Substitutedn-phenyl-1, 3, 4-Oxadiazol-2-Aminecompounds (4a-b) 
General Procedure:  
Compounds (3a-b) (0.5g, 0.00142mmol, 1eq) dissolved in 20mL ethanol. To this mixture 
iodoaceticacid (0.26g, 0.00142mmol, 1eq) was added at 0°C. This reaction mixture heated for 3hrs at 65
°
C. TLC 
was indicated absence of starting materials. The residue was diluted with water and then extracted with dichloro 
methane (30ml*3times). The combined organic layer washed with brine solution and dried with sodium sulphate 
and filtered, concentrated to afford product as dirty white colour. 
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Scheme: Synthetic route of substituted 2-amino-1,3,4-oxodiazoleses 
3. Results and Discussion: 
Spectral details of 2-bromobenzohydrazide(2a) 
Mass (m/z): Calculated M.W: 215.25, Observed M.W: 218.0 (M+3) 
1
H NMR (400 MHz, DMSO –d6):  = 9.5(-NH, s, 1H), 4.48(-NH2, S, 1H), Ar(C-H) = 7.34(m, 2H), 7.40-7.44(d, 
1H), 7.64-7.66x(d, 1H) 
Spectral details of 2-hydroxybenzohydrazide (2b) 
Mass (m/z): Calculated M.W: 152.15, Observed M.W: 153.42 (M+1) 
1
H NMR (400 MHz, DMSO –d6):  = 10.61(Ar-OH, s, 1H), 9.5(-NH, s, 1H), 4.48(-NH2, S, 1H), Ar(C-H) = 
7.398(m, 2H), 7.33-7.5(d, 1H), 7.401-7.419(d, 1H) 
Spectral details of 1-(2-bromobenzoyl)-4-phenylthiosemicarbazide(3a) 
Mass (m/z): Calculated M.W: 350.0, Observed M.W: 352.8 (M+3)- Figure 1 
1
H NMR (400 MHz, DMSO –d6):  = 9.8(-NH, s, 1H),9.60(-NH, s, 1H), 5.48(-NH, s, 1H), Ar(C-H) = 7.16(m, 
1H), 7.566(m, 1H), 7.580(m, 2H), 7.599-7.602(d, 2H), 7.646(m,1H), 7.652-7.655(d, 1H), 7.860-7.863(d, 1H). – 
Figure 2     
Spectral details of 1-(2-hydroxybenzoyl)-4-phenylthiosemicarbazide(3b) 
Mass (m/z): Calculated M.W: 287.3, Observed M.W: 289.0 (M+1) – Figure 3 
1
H NMR (400 MHz, DMSO –d6):  = 11.87(-NH, s, 1H),9.877(-NH, s, 1H), 3.32(-NH, s, 1H), 10.61(Ar-OH, s, 
1H)Ar(C-H) = 6.96(m, 1H), 6.91-6.94(d, 2H), 7.13-7.16(d, 1H), 7.31-7.34(d, 1H), 7.44(m,3H), 7.88(m, 2H). – 
Figure 4 
Spectral details of 5-(2-bromophenyl)-N-phenyl-1,3,4-oxadiazol-2-amine (4a) 
Mass (m/z): Calculated M.W: 316.0, Observed M.W: 319.0 (M+3) – Figure 5 
1
H NMR (400 MHz, DMSO –d6):  = 3.43(-NH, s, 1H), Ar(C-H) = 7.35(m, 4H), 7.5(m, 4H), 7.84-7.86(d, 1H). 
– Figure 6 
 
Figure 1: Mass spectrum of 1-(2-bromobenzoyl)-4-phenylthiosemicarbazide (3a) 
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Figure 2: 
1
HNMR spectrum of 1-(2-bromobenzoyl)-4-phenylthiosemicarbazide (3a) 
 
Figure 3: Mass spectrum of1-(2-hydroxybenzoyl)-4-phenylthiosemicarbazide (3b) 
 
Figure 4: 
1
HNMR spectrum of1-(2-hydroxybenzoyl)-4-phenylthiosemicarbazide (3b) 
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Figure 5: Mass spectrum5-(2-bromophenyl)-N-phenyl-1,3,4-oxadiazol-2-amine (4a) 
 
Figure 6: 
1
HNMR spectrum of5-(2-bromophenyl)-N-phenyl-1, 3, 4-oxadiazol-2-amine (4a) 
Figure (1-6) revealed the Mass spectra and
1
H NMR of compounds 3a-b, 4a                                      
respectively. Figure 1 and 3 of mass spectrum shows the existence of compounds 3a and 3b. The concerned 
mass of the compound 4a is in good agreement with the observed (319.0 m/z) and calculated value (316.0 m/z) 
were shown in figure (3). Proton NMR strongly empowered for the formation of the product by its δ value of 
compounds 3a, 3b and 4a.The δ value of compounds 3a, 3b and 4a are (δ = 9.8,9.60, 5.48, 7.16, 7.566, 7.580, 
7.599-7.602, 7.646, 7.652-7.655, 7.860-7.863), (δ=11.87,9.877, 3.32, 10.61, 6.96, 6.91-6.94, 7.13-7.16), 7.31-
7.34, 7.44, 7.88) and (δ = 3.43,7.35, 7.5,7.84-7.86) ppm corresponding to the various -NH, -OH, Ar-Hprotons 
were mentioned in Figure (2,4,6). 
4. Conclusion: 
In the present work substituted 5-(2-bromophenyl)-N-phenyl-1,3,4-oxadiazol-2-amine (4a)were 
synthesized successfully from the condensation of compounds (3a), (3b) in the presence of iodoacetic acid. Most 
of the researcher have been synthesized 1,3,4-oxadiazol-2-amine derivatives by using hazardous catalyst 
likethiosemicarbazide, one-pot from isoselenocyanates, using polymer-supported reagents, phosphonium 
mediated reagents, hypervalent Iodine mediatedmethod.Etc,. Which involves long time reaction and significant 
challenges during purification of the products, we have been synthesized the 1,3,4-oxadiazol-2-aminederivatives 
considerably simplified method used by  iodoacetic acid as a cyclodesulfirization agent and using ethanol as 
solvent to provide desired product at 65°C, 3hours without formation of side product with high yield. The 
chemical structures of compound (4a) have been confirmed usingspectral techniques viz. Mass and
1
H-NMR 
were found to be in agreement with the chemical structures expected.  
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